Soluble epoxide hydrolase is an endogenous regulator of obesity-induced intestinal barrier dysfunction and bacterial translocation
- 27 March 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (15) , 8431-8436
Abstract
Significance: Defective intestinal barrier function and enhanced lipopolysaccharide (LPS)/bacterial translocation is a key pathogenic factor in many human diseases, including obesity. To date, the molecular mechanisms leading to intestinal barrier defects are not well understood, and there are no available therapeutic approaches to target intestinal barrier function. Here we show that soluble epoxide hydrolase (sEH) could be a novel therapeutic target of obesity-induced intestinal barrier dysfunction and LPS/bacterial translocation, and that sEH inhibitors, which have been evaluated in human clinical trials targeting other disorders, could be promising agents for prevention or treatment.Keywords
Funding Information
- USDA | National Institute of Food and Agriculture (2016-67017-24423)
- USDA | National Institute of Food and Agriculture (2019-67017-29248)
- HHS | NIH | National Cancer Institute (R03CA218520)
- HHS | NIH | National Cancer Institute (R03CA237795)
- USDA | National Institute of Food and Agriculture (MAS00492)
- HHS | NIH | National Institute of Environmental Health Sciences (R35ES030443)
- HHS | NIH | National Institute of Environmental Health Sciences (P42ES004699)
- NSF | MPS | Division of Mathematical Sciences (1761320)
- HHS | NIH | National Institute of Environmental Health Sciences (R00ES024806)
This publication has 24 references indexed in Scilit:
- Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infectionScience, 2018
- Metabolic endotoxemia with obesity: Is it real and is it relevant?Biochimie, 2016
- Intestinal permeability – a new target for disease prevention and therapyBMC Gastroenterology, 2014
- Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerProgress in Lipid Research, 2014
- Metabolic endotoxemia: a molecular link between obesity and cardiovascular riskJournal of Molecular Endocrinology, 2013
- Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010JAMA, 2012
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010JAMA, 2012
- Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in MiceDiabetes, 2008
- Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes, 2007
- Medical Consequences of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2004